AZN
AstraZeneca PLC
Latest News for AZN
In a report released yesterday, Rajan Sharma from Goldman Sachs maintained a Buy rating on AstraZeneca, with a price target of p16,600.00. The comp......
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. AstraZeneca (~AZN) has updated a Phase I clinical trial called “A Phase I ......
President Donald Trump on Thursday signed an executive order to impose a 100% tariff on imported branded medicines (patented drugs and their active......
AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca Tests Cancer Drug Mix for Safety and Drug Interactions T......
Jefferies analyst Michael Leuchten maintained a Buy rating on AstraZeneca on March 27 and set a price target of p18,000.00. Leuchten covers the Hea......
Citi analyst Graham Parry maintained a Buy rating on AstraZeneca today and set a price target of £170.00. According to TipRanks, Parry is a 2-star ......
Traders can read the latest stock market happenings in our daily wrap-up. ...
J.P. Morgan analyst Richard Vosser maintained a Buy rating on AstraZeneca today and set a price target of £138.30. According to TipRanks, Vosser is......
AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. The CHOICE study, formally titled “A Cross-sectional Survey-based St......
AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. The CHOICE study, formally titled “A Cross-sectional Survey-based St......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 27 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AZN | $203.49 | 0% | 2.05M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |